Application Sponsors
ANDA 078876 | LANNETT CO INC | |
Marketing Status
Application Products
001 | SYRUP;ORAL | 5MG/5ML | 0 | CETIRIZINE HYDROCHLORIDE | CETIRIZINE HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2012-05-11 | |
LABELING; Labeling | SUPPL | 4 | AP | 2016-11-08 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2020-03-03 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 42 |
SUPPL | 4 | Null | 7 |
SUPPL | 5 | Null | 15 |
TE Codes
CDER Filings
LANNETT CO INC
cder:Array
(
[0] => Array
(
[ApplNo] => 78876
[companyName] => LANNETT CO INC
[docInserts] => ["",""]
[products] => [{"drugName":"CETIRIZINE HYDROCHLORIDE","activeIngredients":"CETIRIZINE HYDROCHLORIDE","strength":"5MG\/5ML","dosageForm":"SYRUP;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"CETIRIZINE HYDROCHLORIDE","submission":"CETIRIZINE HYDROCHLORIDE","actionType":"5MG\/5ML","submissionClassification":"SYRUP;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)